CYP11B2 and coronary artery disorder: Our results are in agreement with previous investigations reporting no association between the CYP11B2 c.-344C>T polymorphism and bypass degradation measured by adjusted Gensini score (Ortlepp et al. 2001), stent restenosis (Ryu et al. 2002), caroid IMT (Balkestein et al. 2002; Sarzani et al. 2003) and overall CAD events risk in 2490 healthy men (Payne et al. 2004).